首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cancer Immunology Research

Cancer Immunology Research杂志,由American Association for Cancer Research Inc.出版,于2013年创刊,12 issues/year,出版语言English,ISSN:2326-6066,E-ISSN:2326-6074。

投稿咨询
Cancer Immunology Research
Cancer Immunology Research
Cancer Immunology Research
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
7.9
CiteScore
12.6
期刊收录
SCI、SCIE

Cancer Immunology Research(中文译名:《癌症免疫学研究》),ISSN:2326-6066,EISSN:2326-6074,是American Association for Cancer Research Inc.出版的国际性学术期刊,创刊于2013年,以12 issues/year形式稳定发行,2026年总发文量约131篇。该刊采用非OA开放访问,学科归属为ONCOLOGY - IMMUNOLOGY。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达7.9,2025年期刊CiteScore为12.6,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Cancer Immunology Research长期聚焦医学、肿瘤学及相关产业的技术应用前沿,在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、GERMANY (FED REP GER)、England、Japan、Netherlands、France等为核心发文国家与地区;HARVARD UNIVERSITYDANA-FARBER CANCER INSTITUTE、UNIVERSITY OF CALIFORNIA SYSTEM、UNIVERSITY OF TEXAS SYSTEM、MEMORIAL SLOAN KETTERING CANCER CENTER、UNIVERSITY OF PENNSYLVANIA、JOHNS HOPKINS UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 IMMUNOLOGY 免疫学
2区 2区
是 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
2区 2区
是 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
1区 2区
是 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 22 / 183

88.3

学科:ONCOLOGY SCIE Q1 45 / 333

86.6

学科:IMMUNOLOGY SCIE Q1 16 / 183

91.53

学科:ONCOLOGY SCIE Q1 33 / 333

90.24

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 20 / 181

89.2

学科:ONCOLOGY SCIE Q1 35 / 322

89.3

学科:IMMUNOLOGY SCIE Q1 15 / 181

91.99

学科:ONCOLOGY SCIE Q1 32 / 322

90.22


中国学者近期发文

1
Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppressio

Author:Yang, Fuhan; Zhang, Wentao; Wang, Ruiliang; Mao, Shiyu; Liu, Yong-Qiang; Jiang, Yan-Shan; Yu, Yao; Wu, Pengfei; Yu, Yang; Chen, Hao-Tian; Guo, Ya-Dong; Ma, Hui-Hui; Wang, Wen; Yao, Xudong; Jia, Xin-Ming

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue 3, pp. 387-398. DOI: 10.1158/2326-6066.CIR-25-0873

2
Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ-IRF1-SREBF2 Axi

Author:Xu, Liping; Zhang, Xiaomin; Lai, Xiaowei; Chen, Hongyuan; Liao, Shuangye; Chang, Mingzeng; Wu, Xiaoqing; Rui, Wen; Yang, Juan; Wang, Danyang; Gao, Chengqi; Fang, Ziqian; Zhang, Jianeng; Li, Wende; Li, Bo; Xia, Xiaojun; Zhou, Penghui

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue 3, pp. 478-490. DOI: 10.1158/2326-6066.CIR-25-0242

3
Single-cell spatial immune architectures shape ctDNA release and prognosis in luminal breast cance

Author:Xu, Hengyi; Pu, Pengming; Liu, Jiaqi

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-A037

4
Identification and validation of an explainable predictive model for early diagnosis of non-small cell lung cancer metastasis: A peripheral immune score based on integrative machine learnin

Author:Tian, Jianhui; Xu, Fan; Luo, Bin; Chen, Zhenyang; Yao, Yuan; Liu, Youjun; Yang, Xiaoyu; Yao, Jiangliang; Yao, Wang; Lu, Xinyi; Bao, Yuchen; Zhou, Yiyang; Wu, Jianchun; Li, Minghua; Shi, Wenfei; Cui, Yajing; Wang, Yanhong; Wu, Yunxia; Yang, Yun; Li, Yan

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-A035

5
A retrospective clinical study on the 5-year and 10-year survival rates of postoperative malignant tumor patients treated with DC-CI

Author:Gao, Daiqing; Sun, Weihong; Zhu, Danni; Li, Changyou; Wei, Xiaofang; Xie, Shishun

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-A017

6
Large-scale single-cell and spatial multi-omics elucidate the mechanism by which mitochondrial copper metabolism biomarkers promote immune evasion in breast cance

Author:Chu, Bowen; Tong, Xin; Tang, Xinhao; Wang, Xiaoya; Tian, Xinyu; Zhang, Rui; Jiang, Yijun; Yan, Shuai; Hao, Shuai

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-A038

7
Phase 1 Monotherapy and Combination Data for HCB101, a Novel SIRPα-Fc Innate Checkpoint Fusion Protei

Author:Ning, Fangling; Iannotti, Nicholas O.; Cheng, Wei-Hong; Lin, Chia-Chi; Ma, Ji; Mu-Hsin. Chang, Peter; Wang, Ying; Edenfield, William Jeffery.; Li, Wenyu; Zhang, Tian; Zhang, Jian; Chen, Guohua; Mo, Fei; Yu, Langtian Abigail.; Luk, Alvin

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-B076

8
Association of different TP53 mutation subtypes with the efficacy of first-line immunotherapy in locally advanced and metastatic lung squamous cell carcinom

Author:Liang, Yingyun; Yang, Ying; Lu, Shun

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-B064

9
FAM135B Deficiency Inhibits Cytotoxic T-cell Activity in Triple-Negative Breast Cancer by Blocking the IFI16-Dependent STING Pathwa

Author:Lin, Wanmei; Li, Junze; Wu, Jun; Huang, Bin; Liang, Junguang; Zhang, Yuan; Zhao, Liang; Yao, Guangyu

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue 2, pp. 335-349. DOI: 10.1158/2326-6066.CIR-25-0310

10
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunit

Author:Chantzoura, Eleni; Altman-Sharoni, Efrat; Michelet, Xavier; Popis, Martyna C.; Niedzielska, Magdalena; Joshi, Bishnu; Masakayan, Reed; Rubi-Sans, Gerard; Addis, Stephen; Keith, Justin G.; Krishnan, Shanmugarajan; Choi, Jin San; Sanders, Stephanie; Sebastian-Yague, Alvaro; Boi, Shannon K.; Pinzan-Rossi, Moira; Antonopoulos, Georgios; Ibbett, Paul; Wright, Deborah E.; Le Tonqueze, Olivier; Kushner, Nick; Pathak, Chinar; Soh, Kah Teong; Chalmers, Amy L.; Smith, Rachel; Venkatraman, Vignesh; Farahi, Sara; Pravin, John; Iyer, Priyadarshini; Briend, Emmanuel; Ignatovich, Olga; Purbhoo, Marco A.; Curiel, Tyler J.; Exley, Mark A.; Stein, Robert B.; Kim, Enoch; Buell, Jennifer S.; van Dijk, Marc A.; Chand, Dhan

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue 2, pp. 243-260. DOI: 10.1158/2326-6066.CIR-25-0349


在线咨询

Cancer Immunology Research

国际简称:CANCER IMMUNOL RES参考译名:癌症免疫学研究

年发文量:131 CiteScore:12.6 是否预警:否 Gold OA文章占比:32.68% 研究类文章占比:94.66%

杂志社联系方式:615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Cancer Immunology Research